External Validation of the Ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors Into O-RADS Risk Groups

IMPORTANCE: Correct diagnosis of ovarian cancer results in better prognosis. Adnexal lesions can be stratified into the Ovarian-Adnexal Reporting and Data System (O-RADS) risk of malignancy categories with either the O-RADS lexicon, proposed by the American College of Radiology, or the International...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA oncology 2023-02, Vol.9 (2), p.225-233
Hauptverfasser: Timmerman, Stefan, Valentin, Lil, Ceusters, Jolien, Testa, Antonia C, Landolfo, Chiara, Sladkevicius, Povilas, Van Holsbeke, Caroline, Domali, Ekaterini, Fruscio, Robert, Epstein, Elisabeth, Franchi, Dorella, Kudla, Marek J, Chiappa, Valentina, Alcazar, Juan L, Leone, Francesco P. G, Buonomo, Francesca, Coccia, Maria Elisabetta, Guerriero, Stefano, Deo, Nandita, Jokubkiene, Ligita, Kaijser, Jeroen, Scambia, Giovanni, Andreotti, Rochelle, Timmerman, Dirk, Bourne, Tom, Van Calster, Ben, Froyman, Wouter
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:IMPORTANCE: Correct diagnosis of ovarian cancer results in better prognosis. Adnexal lesions can be stratified into the Ovarian-Adnexal Reporting and Data System (O-RADS) risk of malignancy categories with either the O-RADS lexicon, proposed by the American College of Radiology, or the International Ovarian Tumor Analysis (IOTA) 2-step strategy. OBJECTIVE: To investigate the diagnostic performance of the O-RADS lexicon and the IOTA 2-step strategy. DESIGN, SETTING, AND PARTICIPANTS: Retrospective external diagnostic validation study based on interim data of IOTA5, a prospective international multicenter cohort study, in 36 oncology referral centers or other types of centers. A total of 8519 consecutive adult patients presenting with an adnexal mass between January 1, 2012, and March 1, 2015, and treated either with surgery or conservatively were included in this diagnostic study. Twenty-five patients were excluded for withdrawal of consent, 2777 were excluded from 19 centers that did not meet predefined data quality criteria, and 812 were excluded because they were already in follow-up at recruitment. The analysis included 4905 patients with a newly detected adnexal mass in 17 centers that met predefined data quality criteria. Data were analyzed from January 31 to March 1, 2022. EXPOSURES: Stratification into O-RADS categories (malignancy risk
ISSN:2374-2437
2374-2445
DOI:10.1001/jamaoncol.2022.5969